Modulation of bone mass, strength, and turnover by a new benzamide compound, DU-6712, in adjuvant-induced arthritic rats

Calcified Tissue International

Volumn 62, Issue 6, 1998, Pages 519-526

  Uchiyama, Y ^a   Takamori, H ^a   Miyama, K ^a   Takano, E ^a   Nakajima, H ^a   Sato, T ^a   Nakamura, T ^b  

^a DAIICHI SANKYO CO   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Histomorphometry; Inflammation; Mechanical test; Secondary osteoporosis; Serum osteocalcin

Indexed keywords

BENZAMIDE DERIVATIVE; DU 6712; N (4 CHLOROPHENYL) 3 (4 METHYL 1 PIPERAZINYL) 2 NITROBENZAMIDE; OSTEOCALCIN; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MASS; BONE MINERAL; BONE STRENGTH; BONE TURNOVER; CONTROLLED STUDY; FEMALE; LUMBAR SPINE; MORPHOMETRICS; MYCOBACTERIUM BUTYRICUM; NONHUMAN; ORAL DRUG ADMINISTRATION; OSSIFICATION; OSTEOCLAST; OSTEOPOROSIS; PAW EDEMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TRABECULAR BONE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BENZAMIDES; BODY WEIGHT; BONE AND BONES; BONE DENSITY; FEMALE; LUMBAR VERTEBRAE; OSTEOCALCIN; RATS; RATS, INBRED LEW;

EID: 0031744782     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900472     Document Type: Article

References (28)

1. Joffe I, Epstein S (1993) Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum 20:256-272
2. Meijer FE, Papapoulos SE, Paassen HC, Dijkmans BC, Valkema R, Westedt ML, Landman JO, Pauwels EK, Breedveld FC (1996) Increased bone mass with pamidronate treatment in rheumatoid arthritis. Arthritis Rheum 39:396-402
3. Ralston SR, Urquhart GDK, Brezeski M, Sturrock R (1990) Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. Br Med J 300:563-565
4. Hooyman JR, Melton LJ III, Nelson AM, O'Falkm WM, Riggs BL (1984) Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 27:1353-1361
5. Beat AM, Bloch DA, Fries JF (1991) Predictors of fractures in early rheumatoid arthritis. J Rheumatol 18:804-808
6. Spector TD, Hall GM, McCloskey EV, Kanis JA (1993) Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 306:558-561
7. Michael BA, Bloch DA, Wolfe F, Preis JF (1993) Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 20:1661-1669
8. Gough AKS, Liley J, Eyre S, Holder RL, Emery P (1994) Generalized bone loss in patients with early rheumatoid arthritis. Lancet 344:23-27
9. Sambrook PN (1994) Osteoporosis in rheumatoid arthritis: What is the role of antirheumatic therapy. Lancet 344:3-4
10. Compston JE, Vedi S, Croucher PI, Garrahan NJ, O'Sullivan MM (1994) Bone turnover in non-steroid-treated rheumatoid arthritis. Ann Rheum Dis 53:163-166
11. Pitt P, Compston J, Trived P, Salisbury J, Berry H, Moniz C, Parsons V (1994) Systemic bone changes accompanying early rheumatoid arthritis in patients treated with nonsteroidal antiinflammatory drugs alone. Clin Orthop 298:250-258
12. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319:516-518
13. Stashenko P, Dewhrist FE, Rooney ML, Dejardins LA, Heeley D (1987) Interleukin-1β is a potent inhibitor of bone formation in vitro. J Bone Miner Res 2:559-565
14. Nguyen L, Dewhrist FE, Hauschka PV, Stashenko P (1991) Interleukin-1 β stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 10:15-21
15. Kitamura H, Kawata H, Takahashi F, Higuchi Y, Furuichi T, Ohkawa H (1995) Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. Am J Pathol 147:1682-1692
16. Kawaguchi HK, Pilbeam CC, Harrison JK, Raisz LG (1995) The role of prostaglandins in the regulation of bone metabolism. Clin Orthop 313:36-46
17. Ralston SH, Grabowski PS (1996) Mechanisms of cytokineinduced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. Bone 19:29-33
18. Othmane O, Touraine JL, Sanhadji K (1985) A new immunomodulator, LF-1695-I. In vitro effects on the T lymphocyte lineage in man. Int J Immunopharmacol 7:543-548
19. Kawagoe K, Burford SC, Yokohama S, Nakayama A, Hasegawa M, Tsubokawa M, Takamori H, Nakajima H, Miwa T (1995) Antirheumatics: synthesis and structure-activity relationships of 1,2,3-substituted benzamides. AFMC International Medical Chemistry Symposium, abstract 31
20. Andersson GN, Marks SJ (1989) Tartrate-resistant acid ATPase as a cytochemical marker for osteoclast. J Histochem Cytochem 37:115-117
21. Parfitt AM, Mathews CH, Villanueva AR, Kleerkoper M, Frame B. Rao DS (1983) Relationship between surface, volume and thickness of iliac trabecular bone in aging and osteoporosis: implications for the microanatomic and cellular mechanisms for bone loss. J Clin Invest 72:1396-1408
22. Murakami H, Nakamura T, Tsurukami H, Abe M, Barbier A, Suzuki K (1994) Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy. J Bone Miner Res 9:1355-1364
23. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche HH, Meunier PH, Otto SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res 6:595-610
24. Katsumata T, Nakamura T, Ohnishi H, Sakurama T (1995) Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats. J Bone Miner Res 10:921-931
25. Anonymous (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646-650
26. Segawa Y, Nakamura T, Aota S, Tanaka Y, Yoshida K, Tsuzuike N, Matsuda K (1995) Changes in urinary deoxypyridinoline level and vertebral bone mass in the development of adjuvant-induced arthritis in rats. Bone 17:57-62
27. Aota S, Nakamura T, Suzuki K, Tanaka Y, Okazaki Y, Segawa Y, Miura M, Kikuchi S (1996) Effects of indomethacin administration on bone turnover and bone mass in adjuvant-induced arthritis in rats. Calcif Tissue Int 59 (in press)
28. Bonnet J (1993) Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect. J Bone Miner Res 8:659-668